Literature DB >> 2230846

Fatal or severely disabling cerebral infarction during hospitalization for stroke or transient ischemic attack.

G W Petty1, T K Tatemichi, R L Sacco, J Owen, J P Mohr.   

Abstract

Six (1%) of 578 patients admitted for cerebral infarction or transient ischemic attack (TIA) suffered a fatal or severely disabling in-hospital cerebral infarction following a period of stabilization or improvement lasting more than 1 day. These infarctions were characterized by the sudden onset of stupor or coma and subsequent development of transtentorial herniation due to carotid or middle cerebral artery territory infarction, or widespread brain-stem infarction due to basilar occlusion. Only one patient survived. Four patients had large-vessel disease documented by Doppler, angiography, or at autopsy. Each of these six infarcts occurred during the morning hours, 4-9 days after the initial event, 3-8 days after initiation of intravenous heparin, and within 4-8 h after intravenous heparin had been discontinued. No coagulation abnormalities were documented. We believe that these cases indicate that among patients admitted for cerebral infarction or TIA, fatal or severely disabling in-hospital cerebral infarction after a period of stabilization or improvement may occur in patients having an initially mild to moderate clinical deficit, that those suffering large artery disease may be at greater risk, and that there may be a relationship between heparin withdrawal and cerebral infarction in some patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2230846     DOI: 10.1007/bf00314748

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  14 in total

1.  Protein C in acute stroke.

Authors:  A D'Angelo; G Landi; S Vigano'D'Angelo; E Nobile Orazio; E Boccardi; L Candelise; P M Mannucci
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

2.  Is the circadian change in hematocrit and blood viscosity a factor triggering cerebral and myocardial infarction?

Authors:  K Kubota; T Sakurai; J Tamura; T Shirakura
Journal:  Stroke       Date:  1987 Jul-Aug       Impact factor: 7.914

3.  Circadian variations of plasma catecholamine, cortisol and immunoreactive insulin concentrations in supine subjects.

Authors:  M B Turton; T Deegan
Journal:  Clin Chim Acta       Date:  1974-09-30       Impact factor: 3.786

4.  Antithrombin III levels during heparin therapy.

Authors:  A K Rao; S Niewiarowski; J Guzzo; H J Day
Journal:  Thromb Res       Date:  1981 Oct 1-15       Impact factor: 3.944

5.  Circadian variation in the frequency of onset of acute myocardial infarction.

Authors:  J E Muller; P H Stone; Z G Turi; J D Rutherford; C A Czeisler; C Parker; W K Poole; E Passamani; R Roberts; T Robertson
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

6.  Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation.

Authors:  B H Chong; W R Pitney; P A Castaldi
Journal:  Lancet       Date:  1982-12-04       Impact factor: 79.321

7.  Heparin-induced thrombocytopenia in patients with cerebrovascular ischemic disease.

Authors:  M Ramirez-Lassepas; R J Cipolle; K A Rodvold; R D Seifert; L Strand; L Taddeini; M Cusulos
Journal:  Neurology       Date:  1984-06       Impact factor: 9.910

8.  Treatment of acute ischemic stroke. Open trial with continuous intravenous heparinization.

Authors:  M Ramirez-Lassepas; M R Quiñones; H H Nino
Journal:  Arch Neurol       Date:  1986-04

9.  Stroke in the Lehigh Valley: risk factors for recurrent stroke.

Authors:  M Alter; E Sobel; R L McCoy; M E Francis; Z Davanipour; F Shofer; L P Levitt; E F Meehan
Journal:  Neurology       Date:  1987-03       Impact factor: 9.910

10.  Diurnal variation in occurrence of strokes.

Authors:  J Marshall
Journal:  Stroke       Date:  1977 Mar-Apr       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.